Unusual Presentations of an Uncommon Ulcerative Disorder

[1]  M. Schaller,et al.  Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. , 2011, Archives of dermatology.

[2]  J. Callen,et al.  Mycophenolate mofetil as therapy for pyoderma gangrenosum. , 2009, Archives of dermatology.

[3]  G. Anhalt,et al.  Treatment of pyoderma gangrenosum with intravenous immunoglobulin , 2007, The British journal of dermatology.

[4]  J. Callen,et al.  Pyoderma gangrenosum: an update. , 2007, Rheumatic diseases clinics of North America.

[5]  A. Forbes,et al.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial , 2005, Gut.

[6]  F. Powell,et al.  Pyoderma gangrenosum: uncommon presentations. , 2005, Clinics in dermatology.

[7]  J. Reichrath,et al.  Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. , 2005, Journal of the American Academy of Dermatology.

[8]  R. Weenig,et al.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria , 2004, International journal of dermatology.

[9]  C. Magro,et al.  Pyoderma gangrenosum: a review , 2003, Journal of cutaneous pathology.

[10]  C. Grin,et al.  Optimal Treatment of Pyoderma Gangrenosum , 2003, American journal of clinical dermatology.

[11]  P. R. Dahl,et al.  Skin ulcers misdiagnosed as pyoderma gangrenosum. , 2002, The New England journal of medicine.

[12]  M. Mokni,et al.  Pyoderma gangrenosum: a report of 21 cases , 2002, International journal of dermatology.

[13]  P. Manson,et al.  Management Strategies for Pyoderma Gangrenosum: Case Studies and Review of Literature , 2001, Annals of plastic surgery.

[14]  P. Driesch,et al.  Pyoderma gangrenosum: a report of 44 cases with follow‐up , 1997, The British journal of dermatology.

[15]  W. Su,et al.  Pyoderma gangrenosum: classification and management. , 1996, Journal of the American Academy of Dermatology.